Intellia Therapeutics (38I.F) Q1 2025 Earnings

27FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-1.39
-1.27
-1.16
-1.04

Details

Expected EPS
-1.2796280448
Actual EPS
-1.221232
Surprise EPS
0.06
Surprise Percent
+4.56%

Description

Intellia Therapeutics (38I.F) has reported earnings of -1.221232 per share for Q1 2025.

0 Comments

Share your thoughts